Structural Relationship and Influence between Open Innovation Capacities and Performances

Abstract

Previous studies related to open innovation have presented piecewise implications in relation to various knowledge management capacities. The study published by Lichtenthaler and Lichtenthaler in 2009 presented a model that combines the various open innovation capacities of firms in view of a mix of knowledge management, dynamic capability and absorptive capacity. Despite these efforts, there have been few empirical studies on the relationships among capacities, or between capacities and performance from an integrated perspective. Therefore, this study seeks to clarify the relationships among knowledge capacities and between knowledge capacities, technological innovation and financial performance at the firm level. Our findings are that the transformative, connective, inventive and absorptive capacities both directly and indirectly affects technological innovation performance; and innovative and desorptive capacities are the key factors connecting technological innovation to financial performance. This study provides managerial implications for the balanced development of the various knowledge capacities and the improvement of technological innovation and financial performance for firm knowledge managers.

Impact of Open Innovation Communities on Enterprise Innovation Performance: A System Dynamics Perspective

“…The number of community users has a positive impact on the number of posts, views, and comments; the numbers of views and comments have a positive impact on the quality of creative ideas; the quality of creative ideas positively affects the number of product releases through the idea adoption rate; and the creative ideas in the posts are eventually transformed into products. Thus, the adoption rate of ideas, the conversion rate of ideas, and number of posts positively affect the number of product releases [62].…”

Developing an Improved Risk-Adjusted Net Present Value Technology Valuation Model for the Biopharmaceutical Industry

“…The biopharmaceutical industry needs a licensing procedure for clinical trials, unlike other industries, which involves the process of verifying whether the drug is safe and effective. The U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) approve such licenses [7]. The U.S. requires all products to undergo pre-clinical research before testing them on people.…”

“…Valuation of drugs under development is particularly necessary for various purposes such as licensing and M&A transactions. Predicting the future value of assets is useful and important in deciding what economic action to take in the future [7].…”

The Evolving Role of IT Departments in Digital Transformation

“…In the digital era, organizations are increasingly tasked with creating and utilizing new content and/or services through the use of advanced information and communication technologies (ICT) to gain a competitive advantage in sustainable development [1][2][3][4]. They compete not only in generating new products and/or services and knowledge, but also in effecting positive social and environmental change [5].…”

“…Strategic organizational transformation holistically addresses the opportunities and risks posed by advanced IT to the organization, and can have major structural effects on the whole business [6,[32][33][34]. The transformation process is complex, chaotic, As previously discussed, each of the above is an example of how non-ICT-oriented organizations can develop and evolve their dynamic capabilities (DCs) to help guide their decisions and actions in their rapidly changing complex environments and sustain a competitive advantage [3,4,25] However, a key question concerning their vision, culture, organizational structure, and model of sustainable development has yet to be answered: What role can and should IT departments play in non-ICT-oriented organizations undergoing digital transformation?…”